FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neuropathology, and concerns treating posttraumatic encephalopathy. That is ensured by intravenous introduction of an effective amount of nuclear cells of umbilical blood prepared by sedimentation or gradient centrifugation of sampled umbilical blood with separating the nuclear cells in the form of packed cells to be resuspended in cooled plasma with a cryoprotector added, freezing and cryogenic storage.
EFFECT: invention provides effective therapy of posttraumatic encephalopathy with lower risk of immune-associated diseases due to the fact that the method for preparing the nuclear cells of umbilical blood eliminates cultivation thereof with a foreign serum added.
8 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING MENTAL AND NEURAL DISORDERS | 2009 |
|
RU2413524C1 |
| AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
| CELL-FREE THERAPEUTIC AGENTS FOR REGENERATIVE MEDICINE AND METHODS FOR PREPARING THEM | 2018 |
|
RU2742034C2 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
| METHOD FOR OBTAINING OF MSC-ASSOCIATED NON-DIFFERENTIATED HEMOPOIETIC PRECURSOR CELLS WITH CD34+/CD133+ PHENOTYPE | 2016 |
|
RU2628092C1 |
| METHOD OF PRODUCING SUSPENSION OF NUCLEAR CELLS OF UMBILICAL BLOOD WITH STANDARD CONCENTRATION | 2014 |
|
RU2590688C2 |
| COMPOSITIONS FOR TREATING CEREBRAL LESIONS | 2016 |
|
RU2710543C2 |
| METHOD FOR STIMULATING SPINAL CORD REGENERATION BY MESENCHYMAL STEM CELLS, WHICH ARE INCLUDED IN THE FIBRIN MATRIX | 2016 |
|
RU2650638C1 |
| METHOD FOR PREPARATION OF MULTIPOTENT STROMAL CELLS FROM CRYO-FROZEN FETOPLACENTAL COMPLEX TISSUES | 2015 |
|
RU2610132C1 |
| METHOD FOR PRODUCING ASSOCIATES OF HEMATOPOIETIC AND STROMAL PROGENITOR CELLS CAPABLE OF SUPPRESSING ACTIVATION AND PROLIFERATION OF ALLOGENIC LYMPHOCYTES | 2019 |
|
RU2722669C1 |
